76 results
Page 4 of 4
DEFA14A
m9g2snn
8 Oct 19
Additional proxy soliciting materials
4:28pm
8-K
klhsfvjpuv6pu354yek
8 Oct 19
Regulation FD Disclosure
4:26pm
DEFA14A
yd31zz0diihr mvsk
4 Oct 19
Additional proxy soliciting materials
4:55pm
8-K
nsrmpga
4 Oct 19
Chardan Advises Health Sciences Acquisitions Corporation on Merger with Immunovant
4:53pm
PREM14A
z05mjt
2 Oct 19
Preliminary proxy related to merger
9:58am
8-K
iw4 co1sk
2 Oct 19
Creating New Publicly Listed FcRn-Focused Company
7:30am
8-K
EX-2.1
cmpw5td wcw
2 Oct 19
Creating New Publicly Listed FcRn-Focused Company
7:30am
8-K
EX-99.1
ubdo7 ljlzahh
2 Oct 19
Creating New Publicly Listed FcRn-Focused Company
7:30am
DEFA14A
EX-2.1
8rq7qm
2 Oct 19
Additional proxy soliciting materials
7:28am
DEFA14A
i7y9z18w815554baex
2 Oct 19
Additional proxy soliciting materials
7:28am
DEFA14A
EX-99.1
vs0q u6w4cx
2 Oct 19
Additional proxy soliciting materials
7:28am
424B4
dkd qir1d9x1
10 May 19
Prospectus supplement with pricing info
5:18pm
S-1
3zlkwfjdpgowl
15 Apr 19
IPO registration
9:56pm
DRS/A
wxa mtr5v
26 Feb 19
Draft registration statement (amended)
12:00am
DRS
om7fhvoeo3 4sduiq8h
23 Jan 19
Draft registration statement
12:00am